Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
2.040
-0.020 (-0.97%)
At close: Feb 21, 2025, 4:00 PM
2.146
+0.106 (5.20%)
After-hours: Feb 21, 2025, 7:12 PM EST
Milestone Pharmaceuticals Employees
Milestone Pharmaceuticals had 47 employees as of December 31, 2023. The number of employees increased by 8 or 20.51% compared to the previous year.
Employees
47
Change (1Y)
8
Growth (1Y)
20.51%
Revenue / Employee
n/a
Profits / Employee
-$909,936
Market Cap
135.13M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
MIST News
- 3 days ago - Milestone® Pharmaceuticals Notice of Allowance on New U.S. Patent for Etripamil - GlobeNewsWire
- 11 days ago - Milestone Pharmaceuticals to Host Commercial Launch Plan Investor Event in New York on February 25, 2025 - GlobeNewsWire
- 25 days ago - Milestone Pharmaceuticals Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC - GlobeNewsWire
- 6 weeks ago - Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update - GlobeNewsWire
- 6 months ago - Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China - GlobeNewsWire
- 6 months ago - Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors - GlobeNewsWire
- 7 months ago - Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Regulatory and Corporate Update - GlobeNewsWire